Sangamo Therapeutics, Inc. , a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2024 financial results after the market closes on Thursday,.
Sangamo Therapeutics, Inc. , a genomic medicine company, announced today that the company has scheduled the release of its first quarter 2024 financial results after the market closes on Thursday, May 9, 2024.
The company will hold a conference.
StockNews.com initiated coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on the company. Royal Bank of Canada reaffirmed a sector perform rating and set a $2.00 price […]
StockNews.com started coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on SGMO. HC Wainwright restated a buy rating and set a $5.00 price target (up previously […]
Sangamo Therapeutics (NASDAQ:SGMO) Coverage Initiated at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.